Sillem M, Parviz M, Woitge HW, et al. Add-back medrogestone does not prevent bone loss in premenopausal women treated with goserelin. Exp Clin Endocrinol Diabetes 1999;107:379–385.
412.
Taskin O, Uryan I, Yalcinoglu I, et al. Effectiveness of tibolone on hypoestrogenic symptoms induced by goserelin treatment in patients with endometriosis. Fertil Steril 1997;67:40–45.
413.
Lindsay PC, Shaw RW, Bennink HJC, et al. The effect of add-back treatment with tibolone (Livial) on patients treated with the GnRHa triptorelin (Decapeptyl). Fertil Steril 1996;65:342–348.
414. Franke HR, van de Weijere PHM, Pennings TMM, et al. Gonadotropin-releasing hormone agonist plus “add-back” hormone replacement therapy for treatment of endometriosis: a prospective randomized placebo-controlled double-blind trial. Fertil Steril 2000;74:534–539.
415.
Sagsveen M, Farmer JE, Prentice A, et al. Gonadotrophinreleasing hormone analogues for endometriosis: bone mineral density. Cochrane Database Syst Rev 2003;4:CD001297.
416.
Pierce SJ, Gazvani MR, Farquharson RG. Long-term use of gonadotropin-releasing hormone analogs and hormone replacement therapy in the management of endometriosis: a randomized trial with a 6-year follow-up. Fertil Steril 2000;74:964–968.
417.
Tahara M, Matsuoka T, Yokoi T, et al. Treatment of endometriosis with a decreasing dosage of gonadotropin-releasing hormone agonist (nafarelin): a pilot study with low-dose agonist therapy (“draw-back” therapy). Fertil Steril 2000;73:799–804 418.
Yano S, Ikegami Y, Nakao K. Studies on the effect of the new non-steroidal aromatase inhibitor fadrozole hydrochloride in an endometriosis model in rats. Arzneimittelforschung 1996;46:192– 195.
419.
Kudoh M, Susaki Y, Ideyama Y, et al. Inhibitory effects of a novel aromatase inhibitor, YM511, in rats with experimental endometriosis. J Steroid Biochem Mol Biol 1997;63:1–3.
420.
Takayama K, Zeitoun K, Gunby RT, et al. Treatment of severe postmenopausal endometriosis with an aromatase inhibitor. Fertil Steril 1998;69:709–713.
421.
Nawathe A, Patwardhan S, Yates D, et al. Systematic review of the effects of aromatase inhibitors on pain associated with endometriosis. BJOG 2008;115:818–822.
422.
Soysal S, Soysal M, Ozer S, et al. The effects of post-surgical administration of goserelin plus anastrazole compared to goserelin alone in patients with severe endometriosis: a prospective randomised trial. Hum Reprod 2004;19:160–167.
423.